Tesamorelin 10mg

Performance Profile

• GHRH Receptor Agonism: A stabilised version of the body’s own Growth Hormone-Releasing Hormone — modified to last longer in research settings while retaining the same receptor activity as the natural molecule.
• Visceral Adipose Research: Investigated for how GHRH receptor activation affects visceral fat biology and GH-mediated metabolic pathways in adipose tissue research models.
• Lipid Metabolism Research: Studied for effects on triglyceride levels and lipid profile regulation in hepatic and metabolic pathway models.
• Cognitive Research: Emerging research examines potential activity in brain health and executive function models in aging research contexts.

Quick Summary

• Best For: Visceral adipose tissue biology, GHRH receptor pharmacology, lipid metabolism research.
• Use Case: Investigating GH-mediated fat reduction mechanisms and metabolic pathway activity in visceral adipose models.
• Research Context: One of the few GHRH analogues studied in FDA-sanctioned human clinical trials — well-characterised with extensive clinical data.
• Commonly Studied With: Ipamorelin in combined GH axis research protocols.

For research purposes only. Not for human consumption. For use by licensed researchers only. These compounds have not been evaluated or approved by Health Canada for human use.